Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6823
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease ; volume:21 ; number:1 ; day:3 ; month:8 ; year:2021 ; pages:1-7 ; date:12.2021
BMC endocrine disorders ; 21, Heft 1 (3.8.2021), 1-7, 12.2021
- Urheber
-
Yari, Fatemeh Ali
Shabani, Parisa
Karami, Sara
Sarmadi, Negar
Poustchi, Hossein
Bandegi, Ahmad Reza
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12902-021-00820-8
- URN
-
urn:nbn:de:101:1-2021103000363606069797
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yari, Fatemeh Ali
- Shabani, Parisa
- Karami, Sara
- Sarmadi, Negar
- Poustchi, Hossein
- Bandegi, Ahmad Reza
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
P2.32 Non Alcoholic Fatty Liver is Related to Impaired Arterial Function and Subclinical Atherosclerosis
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
Predictors of subclinical atherosclerosis in HIV
P01-014 – Subclinical atherosclerosis in FMF
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice
RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr −/− mice
Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
P2.32 Non Alcoholic Fatty Liver is Related to Impaired Arterial Function and Subclinical Atherosclerosis
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
Predictors of subclinical atherosclerosis in HIV
P01-014 – Subclinical atherosclerosis in FMF
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice
RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr −/− mice
Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis
Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
P2.32 Non Alcoholic Fatty Liver is Related to Impaired Arterial Function and Subclinical Atherosclerosis
Analysis of non-alcoholic beverages
Non-alcoholic fatty liver disease
Predictors of subclinical atherosclerosis in HIV
P01-014 – Subclinical atherosclerosis in FMF
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Apigenin attenuates atherosclerosis and non-alcoholic fatty liver disease through inhibition of NLRP3 inflammasome in mice
RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr −/− mice